NYSE:MET - Metlife Stock Price, Price Target & More

Metlife trades on the New York Stock Exchange (NYSE) under the ticker symbol "MET."

Metlife declared a quarterly dividend on Friday, July 6th. Stockholders of record on Monday, August 6th will be paid a dividend of $0.42 per share on Thursday, September 13th. This represents a $1.68 dividend on an annualized basis and a dividend yield of 3.75%. The ex-dividend date is Friday, August 3rd. View Metlife's Dividend History.

Metlife declared that its board has approved a stock repurchase plan on Tuesday, May 22nd 2018, which allows the company to repurchase $1,500,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to repurchase up to 3.1% of its stock through open market purchases. Stock repurchase plans are typically an indication that the company's board of directors believes its shares are undervalued.

Metlife Inc (NYSE:MET) announced its quarterly earnings results on Wednesday, May, 2nd. The financial services provider reported $1.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.17 by $0.19. The financial services provider had revenue of $15.15 billion for the quarter, compared to analyst estimates of $15.52 billion. Metlife had a return on equity of 8.70% and a net margin of 6.48%. The company's revenue was up .6% on a year-over-year basis. During the same period last year, the firm earned $1.20 EPS. View Metlife's Earnings History.

17 Wall Street analysts have issued 1-year target prices for Metlife's shares. Their forecasts range from $47.00 to $78.00. On average, they anticipate Metlife's share price to reach $56.60 in the next twelve months. This suggests a possible upside of 26.4% from the stock's current price. View Analyst Ratings for Metlife.

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Metlife in the last year. There are currently 9 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Hold."

Metlife saw a drop in short interest during the month of June. As of June 29th, there was short interest totalling 12,020,672 shares, a drop of 28.9% from the June 15th total of 16,900,543 shares. Based on an average daily volume of 7,086,353 shares, the short-interest ratio is presently 1.7 days. Approximately 1.4% of the shares of the stock are sold short. View Metlife's Current Options Chain.

Some companies that are related to Metlife include China Life Insurance (LFC), Prudential Public (PUK), AXA (AXAHY), Prudential Financial (PRU), Manulife Financial (MFC), SWISS RE Ltd/S (SSREY), AVIVA PLC/ADR (AVVIY), Sun Life Financial (SLF), HANNOVER RUECK/S (HVRRY), Legal & General Group (LGEN), AMP (AMP), Lincoln National (LNC), OLD Mut PLC/ADR (ODMTY), AEGON (AEG) and Torchmark (TMK).

News headlines about MET stock have trended somewhat positive this week, according to Accern Sentiment Analysis. The research firm scores the sentiment of media coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Metlife earned a media sentiment score of 0.20 on Accern's scale. They also gave headlines about the financial services provider an impact score of 44.76 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company's share price in the immediate future.

Metlife's stock is owned by a number of of retail and institutional investors. Top institutional investors include BOARD OF DIRECTORS OF METLIFE INC (15.00%), Bank of Montreal Can (0.19%), NN Investment Partners Holdings N.V. (0.17%), Retirement Systems of Alabama (0.06%), Cambiar Investors LLC (0.05%) and Deprince Race & Zollo Inc. (0.05%). Company insiders that own Metlife stock include Christopher G Townsend, Frans Hijkoop, Gerald L Hassell, James M Kilts, Maria R Morris and Peter M Carlson. View Institutional Ownership Trends for Metlife.

MET stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can, Calamos Advisors LLC, Welch & Forbes LLC, Gofen & Glossberg LLC IL, Cambiar Investors LLC, Jolley Asset Management LLC, Deprince Race & Zollo Inc. and Gateway Investment Advisers LLC. View Insider Buying and Selling for Metlife.

MET stock was bought by a variety of institutional investors in the last quarter, including Howard Capital Management Inc., Capital One National Association, Retirement Systems of Alabama, Farmers Trust Co., DAVENPORT & Co LLC, NN Investment Partners Holdings N.V., Addenda Capital Inc. and State of Alaska Department of Revenue. Company insiders that have bought Metlife stock in the last two years include Gerald L Hassell and James M Kilts. View Insider Buying and Selling for Metlife.

Shares of MET can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of MET stock can currently be purchased for approximately $44.7765.

Metlife has a market capitalization of $44.92 billion and generates $62.09 billion in revenue each year. The financial services provider earns $4.01 billion in net income (profit) each year or $4.50 on an earnings per share basis. Metlife employs 49,000 workers across the globe.

Metlife's mailing address is 200 Park Avenue, New York NY, 10166. The financial services provider can be reached via phone at 212-578-9500.